LC-PDA-01
LC-PDA-01 is a selective peroxiredoxin 1 (PRDX1) activator with an EC50 of 111.8 nM and a human KD of 123.2 nM. LC-PDA-01 inhibits the expression of pro-inflammatory cytokines IL-1β, IL-6 and TNF-α. LC-PDA-01 can be used in antioxidant/anti-inflammatory research.
For research use only. We do not sell to patients.
- Formula: C18H15Cl2N5O4
- Molecular Weight:436.25
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
LC-PDA-01 (100 μM; 3 h) significantly stabilizes endogenous PRDX1 protein in HEK-293T human embryonic kidney cells, as measured by cellular thermal shift assay[1].
LC-PDA-01 (20 μM) significantly suppresses LPS (HY-D1056)-induced expression of IL-1β, IL-6, and TNF-α mRNA in RAW 264.7 mouse macrophages[1].
LC-PDA-01 (Incubated to measure half-life of 381.6 min) shows excellent metabolic stability in mouse liver microsomes, with a half-life of 381.6 min and a hepatic extraction ratio of 13.7%[1].
LC-PDA-01 has low apparent permeability (Papp A→B = 0.06 × 10-6 cm/s) across Caco-2 monolayers, with a high efflux ratio of 5.23, suggesting potential P-gp-mediated active efflux[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Molecular Weight 436.25
-
Formula C18H15Cl2N5O4
-
SMILES
NC1=CC=C(C=C1)C[C@H](C(O)=O)NC(C2=CN(N=N2)C3=CC(Cl)=CC(Cl)=C3O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)